Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Witschi, H.
Right arrow Articles by Uyeminami, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Witschi, H.
Right arrow Articles by Uyeminami, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 7, 1375-1378, July 1999
© 1999 Oxford University Press


Short Communications

Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone

Hanspeter Witschi1, Imelda Espiritu and Dale Uyeminami

Institute of Toxicology and Environmental Health and Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA 95616, USA

Male A/J strain mice were fed AIN-76A diet supplemented with myo-inositol/dexamethasone (10 g and 0.5 mg/kg diet) or acetylsalicylic acid (300 mg/kg) and exposed for 5 months to a mixture of sidestream and mainstream cigarette smoke at a concentration of 132 mg total suspended particulates/m3. After tobacco smoke exposure, they were allowed to recover for another 4 months in filtered air. In the animals fed AIN-75A diet alone or acetylsalicylic acid, the average number of tumors/lung was 2.1, whereas in the animals given the myo-inositol/dexamethasone diet, the average lung tumor multiplicity was 1.0 (P < 0.05). In animals exposed to filtered air, lung tumor multiplicities were 0.6 for animals fed AIN-76A or myo-inositol/dexamethasone and 1.2 for animals fed acetylsalicylic acid. It was concluded that the combination of myo-inositol and dexamethasone constitutes an effective chemopreventive regimen against tobacco smoke-induced lung tumorigenesis.

Abbreviations: B[a]P, benzo[a]pyrene; NAC, N-acetylcysteine; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; PEITC, phenethylisothiocyanate; TSP, total suspended particulates.

1 To whom correspondence should be adressed at: ITEH, University of California, 1 Shields Avenue, Davis, CA 95616, USA Email: hrwitschi{at}ucdavis.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Vet PatholHome page
A. K. Bauer and E. A. Rondini
REVIEW PAPER: The Role of Inflammation in Mouse Pulmonary Neoplasia
Vet. Pathol., May 1, 2009; 46(3): 369 - 390.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
T. E. Johnson, F. Kassie, M. G. O'Sullivan, M. Negia, T. E. Hanson, P. Upadhyaya, P. P. Ruvolo, S. S. Hecht, and C. Xing
Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[a]pyrene-Induced Lung Tumorigenesis in A/J Mice
Cancer Prevention Research, November 1, 2008; 1(6): 430 - 438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger
Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. M. Curtin, M. A. Higuchi, P. H. Ayres, J. E. Swauger, and A. T. Mosberg
Lung Tumorigenicity in A/J and rasH2 Transgenic Mice Following Mainstream Tobacco Smoke Inhalation
Toxicol. Sci., September 1, 2004; 81(1): 26 - 34.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. R. Kisley, B. S. Barrett, L. D. Dwyer-Nield, A. K. Bauer, D. C. Thompson, and A. M. Malkinson
Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice
Carcinogenesis, October 1, 2002; 23(10): 1653 - 1660.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Witschi, I. Espiritu, S. T. Dance, and M. S. Miller
A Mouse Lung Tumor Model of Tobacco Smoke Carcinogenesis
Toxicol. Sci., August 1, 2002; 68(2): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Pereira, Y. Li, W. T. Gunning, P. M. Kramer, F. Al-Yaqoub, R. A. Lubet, V. E. Steele, E. Szabo, and L. Tao
Prevention of mouse lung tumors by budesonide and its modulation of biomarkers
Carcinogenesis, July 1, 2002; 23(7): 1185 - 1192.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. T. Bogen and H. Witschi
Lung tumors in A/J mice exposed to environmental tobacco smoke: estimated potency and implied human risk
Carcinogenesis, March 1, 2002; 23(3): 511 - 519.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Witschi, I. Espiritu, M. Suffia, and K. E. Pinkerton
Expression of cyclin D1/2 in the lungs of strain A/J mice fed chemopreventive agents
Carcinogenesis, February 1, 2002; 23(2): 289 - 294.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. De Flora, A. Izzotti, F. D'Agostini, and R. M. Balansky
Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points
Carcinogenesis, July 1, 2001; 22(7): 999 - 1013.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Witschi, D. Uyeminami, D. Moran, and I. Espiritu
Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure
Carcinogenesis, May 1, 2000; 21(5): 977 - 982.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.